Table 1

Comparison between CA9 expression and pimonidazole binding in cervical cancers

Patient	Age	Smoker	FIGO^a cervical cancer stage	Histology	% Pimopositive area	% CA9- positive area
1	49	No	IIb	Squamous	13.6	27.7
2	71	No	IVa	Squamous	6.4	18.3
3	59	No	IIb	Adeno	3	14
4	34	Yes	IIb	Squamous	5.7	13
5	46	Yes	IIIb	Squamous	8.1	11.7
6	52	No	1b₂	Squamous	5.7	11.4
7	59	No	IIIb	Squamous	5.1	10
8	33	Yes	1b₂	Squamous	3.6	7.1
9	47	No	1b₁	Adeno	4.3	7
10	42	No	IIa	Adeno	3.1	6.9
11	67	No	1b₂	Adeno	4.6	6.2
12	33	Yes	IIb	Squamous	3.1	4.4
13	43	No	IIb	Squamous	2.3	4
14	38	No	1b₂	Squamous	1.2	2
15	41	No	1b₁	Adeno	1.1	2
16	41	No	1b₁	Squamous	1.4	1.8
17	35	Yes	1b₂	Squamous	5.1	1.6
18	41	Yes	1b₂	Squamous	1.4	1.6

a FIGO, Fédération Internationale des Gynecologistes et Obstetristes; Pimo, pimonidazole; Adeno, adenocarcinoma.